Organon stock performance snapshot Organon (OGN) has recently drawn investor attention after a strong month, with the share ...

Organon (OGN) ended the recent trading session at $9.00, demonstrating a -1.1% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.41%.

Organon (OGN) closed at $10.45 in the latest trading session, marking a -3.69% move from the prior day. This move lagged the S&P 500's daily gain of 0.49%. Elsewhere, the Dow saw an upswing of 0.38%, ...

If you are wondering whether Organon is a bargain or a value trap at its current price, you are in the right place. This ...

The average one-year price target for Organon (NYSE:OGN) has been revised to $11.05 / share. This is a decrease of 15.36% from the prior estimate of $13.06 dated September 27, 2025. The price target ...

Agnico Eagle Mines (AEM) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE:OGN), a ...

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars ...

Sun Pharma has addressed speculation regarding a potential $10 billion acquisition of US firm Organon. The Indian drugmaker ...

Investing.com-- India’s Sun Pharmaceutical Industries (NSE:SUN) is evaluating a potential acquisition of U.S.-based women’s health drugmaker Organon & Co (NYSE:OGN) in a deal that could be valued at ...